Treatment of inflammatory skin disease
US10844118B2 · kind B2 · utility
2Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 2014 |
| Grant date | Nov 24, 2020 |
| Priority date | — |
| Expiry date | Mar 10, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/202
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The methods, compositions, and assays described herein are based, in part, on the discovery that CD1a mediates inflammation related to certain conditions such as urushiol exposure, psoriasis and other inflammatory skin diseases. One aspect provided herein relates to a method for treating or preventing an inflammatory skin disease, the method comprising: administering a therapeutically effective amount of an inhibitor of CD 1a to a subject having an inflammatory skin disease, thereby treating or preventing the inflammatory skin diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.